Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JACC: CardioOncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Outcomes by Class of Anticoagulant Use for Nonvalvular Atrial Fibrillation in Patients With Active Cancer
JACC CardioOncology 2022 Sep 01;4(3)341-350, AS Potter, A Patel, M Khawaja, C Chen, H Zheng, J Kaczmarek, F Gao, K Karimzad, J Song, E Koutroumpakis, S Khalaf, C Iliescu, A Deswal, NL PalaskasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.